Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV.

MLA

Xuhua Xiao, et al. “Case Report: Complete Response after Transcatheter Arterial Chemoembolization Combined with Donafenib plus Tislelizumab Therapy for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus in a Patient Coinfected with HIV and HBV.” Frontiers in Immunology, July 2024, pp. 1–7. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1422801.

APA

Xuhua Xiao, Haixiao Fu, Huixia Qin, Longkuan Xu, Jing Gu, Zhan Zhang, Houxiang Ya, Kaiwen Jiang, Zhiyuan Jian, & Shuqun Li. (2024). Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV. Frontiers in Immunology, 1–7. https://doi.org/10.3389/fimmu.2024.1422801

Chicago

Xuhua Xiao, Haixiao Fu, Huixia Qin, Longkuan Xu, Jing Gu, Zhan Zhang, Houxiang Ya, Kaiwen Jiang, Zhiyuan Jian, and Shuqun Li. 2024. “Case Report: Complete Response after Transcatheter Arterial Chemoembolization Combined with Donafenib plus Tislelizumab Therapy for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus in a Patient Coinfected with HIV and HBV.” Frontiers in Immunology, July, 1–7. doi:10.3389/fimmu.2024.1422801.